Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic Pain

NCT02217267 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Peripheral Neuropathy

Interventions

DRUG: Lidocaine
DRUG: Placebo

Sponsor

Mahidol University